316 related articles for article (PubMed ID: 28032863)
1. Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells.
Celeghin A; Giunco S; Freguja R; Zangrossi M; Nalio S; Dolcetti R; De Rossi A
Cell Death Dis; 2016 Dec; 7(12):e2562. PubMed ID: 28032863
[TBL] [Abstract][Full Text] [Related]
2. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies.
Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A
Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223
[TBL] [Abstract][Full Text] [Related]
3. Extra-telomeric functions of telomerase in the pathogenesis of Epstein-Barr virus-driven B-cell malignancies and potential therapeutic implications.
Giunco S; Petrara MR; Zangrossi M; Celeghin A; De Rossi A
Infect Agent Cancer; 2018; 13():14. PubMed ID: 29643934
[TBL] [Abstract][Full Text] [Related]
4. Short-Term TERT Inhibition Impairs Cellular Proliferation via a Telomere Length-Independent Mechanism and Can Be Exploited as a Potential Anticancer Approach.
Amin A; Morello M; Petrara MR; Rizzo B; Argenton F; De Rossi A; Giunco S
Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345011
[TBL] [Abstract][Full Text] [Related]
5. Anti-Proliferative and Pro-Apoptotic Effects of Short-Term Inhibition of Telomerase In Vivo and in Human Malignant B Cells Xenografted in Zebrafish.
Giunco S; Zangrossi M; Dal Pozzolo F; Celeghin A; Ballin G; Petrara MR; Amin A; Argenton F; Godinho Ferreira M; De Rossi A
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32722398
[TBL] [Abstract][Full Text] [Related]
6. Cross talk between EBV and telomerase: the role of TERT and NOTCH2 in the switch of latent/lytic cycle of the virus.
Giunco S; Celeghin A; Gianesin K; Dolcetti R; Indraccolo S; De Rossi A
Cell Death Dis; 2015 May; 6(5):e1774. PubMed ID: 26018735
[TBL] [Abstract][Full Text] [Related]
7. BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition.
Ding X; Cheng J; Pang Q; Wei X; Zhang X; Wang P; Yuan Z; Qian D
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):861-874. PubMed ID: 31419512
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Telomere Homeostasis during Epstein-Barr virus Infection and Immortalization.
Kamranvar SA; Masucci MG
Viruses; 2017 Aug; 9(8):. PubMed ID: 28792435
[TBL] [Abstract][Full Text] [Related]
9. Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells.
Fagard R; Mouas H; Dusanter-Fourt I; Devillers C; Bissières P; Martin A; Lenoir G; VanTan H; Feuillard J; Raphaël M
Oncogene; 2002 Jul; 21(29):4473-80. PubMed ID: 12085225
[TBL] [Abstract][Full Text] [Related]
10. Reconsideration of senescence, immortalization and telomere maintenance of Epstein-Barr virus-transformed human B-lymphoblastoid cell lines.
Sugimoto M; Ide T; Goto M; Furuichi Y
Mech Ageing Dev; 1999 Feb; 107(1):51-60. PubMed ID: 10197788
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
[TBL] [Abstract][Full Text] [Related]
12. Telomere dysfunction and activation of alternative lengthening of telomeres in B-lymphocytes infected by Epstein-Barr virus.
Kamranvar SA; Chen X; Masucci MG
Oncogene; 2013 Dec; 32(49):5522-30. PubMed ID: 23708666
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
De Leo A; Arena G; Stecca C; Raciti M; Mattia E
Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
[TBL] [Abstract][Full Text] [Related]
14. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
[TBL] [Abstract][Full Text] [Related]
15. Kras mutations increase telomerase activity and targeting telomerase is a promising therapeutic strategy for Kras-mutant NSCLC.
Liu W; Yin Y; Wang J; Shi B; Zhang L; Qian D; Li C; Zhang H; Wang S; Zhu J; Gao L; Zhang Q; Jia B; Hao L; Wang C; Zhang B
Oncotarget; 2017 Jan; 8(1):179-190. PubMed ID: 27329725
[TBL] [Abstract][Full Text] [Related]
16. Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
El-Daly H; Kull M; Zimmermann S; Pantic M; Waller CF; Martens UM
Blood; 2005 Feb; 105(4):1742-9. PubMed ID: 15507522
[TBL] [Abstract][Full Text] [Related]
17. TERT regulates telomere-related senescence and apoptosis through DNA damage response in male germ cells exposed to BPDE in vitro and to B[a]P in vivo.
Ling X; Yang W; Zou P; Zhang G; Wang Z; Zhang X; Chen H; Peng K; Han F; Liu J; Cao J; Ao L
Environ Pollut; 2018 Apr; 235():836-849. PubMed ID: 29353801
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the EBV-Induced Persistent DNA Damage Response.
Hafez AY; Luftig MA
Viruses; 2017 Dec; 9(12):. PubMed ID: 29194355
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
[TBL] [Abstract][Full Text] [Related]
20. Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
Bashash D; Ghaffari SH; Mirzaee R; Alimoghaddam K; Ghavamzadeh A
Leuk Lymphoma; 2013 Mar; 54(3):561-8. PubMed ID: 22957790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
